Expert Advice 12 Sep 2025
Eight biotech career paths where demand is skyrocketing
Check out eight important biotechnology careers that are currently in high demand, and likely still will be in the coming years.
- Latest Posts
Podcast 12 Sep 2025
AION Labs is building innovative biotechs with top pharma partners in Israel
Our guest today is Mati Gill, CEO of AION Labs. AION Labs has an innovative company creation process that empowers startups to tackle high-impact challenges with AI, backed by top-tier data, funding, and expertise.
News and Trends 10 Sep 2025
Kriya Therapeutics has raised over $1.2 billion, but for what?
Gene therapies have witnessed a decline in investor interest in recent times. Despite this, Kriya Therapeutics seems to be attracting funds in the space.
In Depth 10 Sep 2025
When rare diseases are not so rare after all: A closer look at where and why this happens
Discover how in some communities around the world, the prevalence of rare diseases is higher due to factors like cousin marriages.
News and Trends 9 Sep 2025
Top biotech deals in August 2025
Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small molecules.
Advanced expression vector design to overcome challenges in developing multichain biotherapeutics
Learn how multichain biotherapeutics like bispecific antibodies and Fc-fusion proteins overcome manufacturing challenges with advanced vectors and expression systems.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 8 Sep 2025
With Lykos CRL now public, FDA opens new era of accountability
As the release of a CRL declining Lykos’ therapy generates a strong reaction from MAPS, delve into what this new transparency could change.
In Depth 5 Sep 2025
Closing treatment gaps in yellow fever: are germ-free egg-based vaccines the answer?
Germ-free egg-based vaccines could be the answer to curbing yellow fever outbreaks.
Podcast 5 Sep 2025
Navigating the biotech development journey from first steps to global scale with Lonza
Our guests Alice Harrison and Megan Mason from Lonza discuss how the company is helping innovators develop and scale their therapies.
Interview 3 Sep 2025
Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand
As radiopharma is gaining momentum, read our interview with Dr. Delpassand, the CEO of RadioMedix’s, an established company of the field.
In Depth 3 Sep 2025
How are biotechs tackling malaria?
As a recent approval closes a major therapeutic gap, let’s take a look at some of the latest progress and new treatments against malaria.
In Depth 2 Sep 2025
The biggest biotech funding rounds in August 2025
Kriya Therapeutics, Strand Therapeutics, and Minghui Pharmaceutical bagged the biggest biotech funding rounds overall in August 2025.
ADVERTISEMENT
